92528 ⎘
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
Sub-classes:PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES
#2CYCLOHEXYL BETA-HYDROXY ALKYL AMINES AND MEDICAL USES THEREOF
#3Process for preparing beta 3 agonists and intermediates
#4PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES
#5POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE
#6Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#7Process for preparing beta 3 agonists and intermediates
#8Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#9Process for preparing beta 3 agonists and intermediates
#10Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
#11Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#12Process for preparing beta 3 agonists and intermediates
#13Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#14Process for preparing beta 3 agonists and intermediates
#15Inhibiting neurotransmitter reuptake
#16Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#17Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#18Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#19Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#20Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#21Amine derivative compounds for treating ophthalmic diseases and disorders
#22Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#23Treatment of Type 2 Diabetes With FTY720
#24Process for the production of 2-amino-2[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
#25Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#26Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#27Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
#28Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
#29Amines or amino alcohols as GLYT1 inhibitors
#30Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#31Amine derivative compounds for treating ophthalmic diseases and disorders
#32Amine derivative compounds for treating ophthalmic diseases and disorders
#33Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#34PROCESS FOR THE SEPARATION OF ENANTIOMERICALLY PURE COMPOUNDS
#35Process for preparing Cinacalcet
#36Continuous flow synthesis of amino alcohols using microreactors
#37Compositions and methods for the treatment of infectious diseases
#38Reversible room-temperature ionic liquids
#39Process for the production of 2-amino-2-[2-(4-C-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
#40Carbonyl asymmetric alkylation
#41SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#42AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS
#43AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#44Bupropion Metabolites and Methods of Their Synthesis and Use
#45Amine derivative compounds for treating ophthalmic diseases and disorders
#46Compounds Which Modulate The CB2 Receptor
#47Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#48Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
#49CATALYTIC HYDROGENATION PROCESS AND NOVEL CATALYST FOR IT
#50Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#51Treatment of Inflammatory Disorders and Pain
#52AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#53Method of preparing pseudonorephedrine
#54Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
#55Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
#56Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
#57Process for preparation of optically active 1-erythro-2-amino-1-phenyl-1-propanol
#58AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#59Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates
#60Optical resolution of 3-carbamoylmethyl-5-methylhexanoic acid
#61Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates
#62Intermediates of bupropion metabolites synthesis
#63Anti tubercular drug: compositions and methods
#64Process for manufacturing of enantiomerically pure 3-hydroxy-3-phenyl-propylamin
#65Process for producing optically active β-amino alcohol
#66Process for the enantioselective hydrogenation of amino alcohols
#67Histamine-3 receptor antagonists
#68Amine compounds and inhibiting neurotransmitter reuptake
#69Crystalline beta2 adrenergic receptor agonist
#70Method for producing optically active β-phenylalanine compounds
#71Method for preparing sulphostin and analogue thereof or preparation intermediate thereof